Search Results - "Ducloy, A.S"

Recombinant human FVIIa for reducing the need for invasive second‐line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial by Lavigne‐Lissalde, G., Aya, A. G., Mercier, F. J., Roger‐Christoph, S., Chauleur, C., Morau, E., Ducloy‐Bouthors, A. S., Mignon, A., Raucoules, M., Bongain, A., Boehlen, F., Moerloose, P., Bouvet, S., Fabbro‐Peray, P., Gris, J.‐C.

“…Summary Background Case reports on recombinant human factor VIIa (rhuFVIIa) use in women with severe postpartum hemorrhage (PPH) showed encouraging results,…”
Get full text

OC-4a: Comparison of two diagnostic scores of disseminated intravascular coagulation in pregnant women admitted to the ICU by Jonard, M, Ducloy-Bouthors, A.S, François, F

Get full text

Are there any additional mechanisms for haemolysis in HELLP syndrome? by Sabau, L, Terriou, L, Provot, F, Fourrier, F, Roumier, C, Caron, C, Susen, S, Ducloy-Bouthors, A.S

“…Abstract HELLP syndrome is a microangiopathy that leads to severe maternal complications. The objective of this study was to identify any additional mechanisms…”
Get full text

P-012: Thrombin and plasmin generation as measured by a single well technique during haemorrhagic and non-hemorrhagic caesarean section: pilot study by Ducloy-Bouthors, A.S, Jeanpierre, E, Hennart, B, Baptiste, A.S, Giovannoni, S, Saidi, I, Simon, E, Lannoy, D, Allorge, D, Duhamel, A, Susen, S

Get full text

P-011: TRAnexamic acid to reduce blood loss in hemorrhagic CESarean delivery: therapeutic and pharmaco-biological dose-ranging multicenter randomized double blind placebo controlled study: TRACES trial methodology by Ducloy-Bouthors, A.S, Jeanpierre, E, Hennart, B, Baptiste, A, Giovannoni, S, Saidi, I, Simon, E, Lannoy, D, Allorge, D, Duhamel, A, Susen, S

Get full text

P-013: Thrombin and plasmin generation in a well innovative method development: effect of tranexamic acid concentration in vitro by Ducloy-Bouthors, A.S, Jeanpierre, E, Hennart, B, Baptiste, A.S, Giovannoni, S, Saidi, I, Simon, E, Lannoy, D, Allorge, D, Duhamel, A, Susen, S

Get full text

Tranexamic Acid for the Prevention and Treatment of Postpartum Hemorrhage by Sentilhes, L, Lasocki, S, Ducloy-Bouthors, A.S, Deruelle, P, Dreyfus, M, Perrotin, F, Goffinet, F, Deneux-Tharaux, C

“…(Br J Anaesth. 2015;114:576–587)Postpartum hemorrhage (PPH) is a major cause of maternal mortality, accounting for one-quarter of all maternal deaths…”
Get full text

P.4 Preeclampsia as a risk factor for postnatal pulmonary embolism by Wibaut, B, Trillot, N, Deruelle, P, Hatron, P.Y, Lambert, M, Ducloy-Bouthors, A.S

Get full text

Medical Advances in the Treatment of Postpartum Hemorrhage by Ducloy-Bouthors, A.S, Susen, S, Wong, C.A, Butwick, A, Vallet, B, Lockhart, E

“…(Anesth Analg. 2014;119(5):1140–1147)…”
Get full text

Tranexamic Acid for the Prevention and Treatment of Postpartum Hemorrhage by Sentilhes, L, Lasocki, S, Ducloy-Bouthors, A.S, Deruelle, P, Dreyfus, M, Perrotin, F, Goffinet, F, Deneux-Tharaux, C

“…(Br J Anaesth. 2015;114 (4):576–87)Postpartum hemorrhage (PPH) accounts for one quarter of all maternal deaths worldwide, and uterotonic agents are currently…”
Get full text

6% Hydroxyethyl Starch (130/0.4) Versus Ringer Lactate Preloading Before Spinal Anesthesia for Cesarean Delivery: The Randomized, Double-Blind, Multicenter CAESAR Trial by Mercier, F.J, Diemunsch, P, Ducloy-Bouthors, A.S, Mignon, A, Fischler, M, Malinovsky, J.M, Bolandard, F, Aya, A.G, Raucoules-Aimé, M, Chassard, D, Keita, H, Rigouzzo, A, Le Gouez, A

“…(Br J Anaesth. 2014;113(3):459–467)…”
Get full text

P10 ROTEM® analysis for dysfibrinogenemia in pregnancy by Ducloy-Bouthors, A.S, Dalmas-Laurent, A.F, Coutty, N, Bauters, A, Nobecourt, C, Tournoys, A, Wibaut, B, Jude, B

Get full text

P9 Near patient international normalized ratio reliability in obstetrics by Ducloy-Bouthors, A.S, Wierre, F, Barre-Drouard, C, Bauters, A, Nobecourt, C, Boodhun, R, Tournoys, A, Wibaut, B, Jude, B

Get full text

24 Recombinant FVIIa requires fibrinogen to be efficient in severe obstetric haemorrhage – case report by Ducloy-Bouthors, A.S, Provost, N, Bauters, A, Tournoys, A, Wibaut, B

Get full text

25 ROTEM® normal values at the end of pregnancy and immediate post-partum period by Ducloy-Bouthors, A.S, Lejeune, C, Bauters, A, Provost, N, Nobecourt, C, Tournoys, A, Wibaut, B, Jude, B

Get full text

Tranexamic acid for the prevention and treatment of postpartum haemorrhage by Sentilhes, L., Lasocki, S., Ducloy-Bouthors, A.S., Deruelle, P., Dreyfus, M., Perrotin, F., Goffinet, F., Deneux-Tharaux, C.

“…Postpartum haemorrhage (PPH) is a major cause of maternal mortality, accounting for one-quarter of all maternal deaths worldwide. Uterotonics after birth are…”
Get full text

Postpartum haemorrhage related early increase in D-dimers is inhibited by tranexamic acid: haemostasis parameters of a randomized controlled open labelled trial by Ducloy-Bouthors, A.S., Duhamel, A, Kipnis, E, Tournoys, A, Prado-Dupont, A, Elkalioubie, A, Jeanpierre, E, Debize, G, Peynaud-Debayle, E, DeProst, D, Huissoud, C, Rauch, A, Susen, S

“…Beneficial effects of tranexamic acid (TA) have been established in surgery and trauma. In ongoing postpartum haemorrhage (PPH), a moderate reduction of blood…”
Get full text

P005: Is there a link between A5 FIBTEM and plasma fibrinolytic activity in severe postpartum haemorrhage? by Garin-Bastuji, T., Baptiste, A.S., Jeanpierre, E., Bauters, A., Depret-Mosser, S., Ducloy-Bouthors, A.S.

Get full text

Accuracy and Trending Ability of Finger Plethysmographic Cardiac Output Monitoring in Late Pregnancy by Bonnin, P., Constans, B., Duhamel, A., Kyheng, M., Ducloy-Bouthors, A.S., Estevez, M.G., Tavernier, B., Gaudet, A.

“…( Can J Anesth 2022;69:1340–1348) Hemodynamic variation is a well-known part of pregnancy, particularly variation in cardiac output (CO). CO reduction in the…”
Get full text

Hypothesis for a partially non urinary elimination of tranexamic acid in haemorrhagic caesarean section: Traces pilot pharmacokinetic study: Pharmacokinetics of tranexamic acid in obstetrics by Gilliot, S., Ducloy-Bouthors, A.S., Hennart, B., Loingeville, F., Jeanne, M., Lebuffe, G., Odou, P.

“…•The elimination of tranexamic acid given for haemorrhagic caesarean section was shown to be partially non urinary in contrast with healthy patients.•The…”
Get full text